Kyinno Biotechnology (康源博创)
Woburn, Massachusetts, United States
Kyinno is a preclinical contract research organization (CRO) specializing in customized services for drug discovery, including in vitro and in vivo pharmacology, cell line engineering, therapeutic target identification, and innovative antibody discovery. With a robust asset base of over 3,000 engineered cell lines, advanced antibody discovery mouse models, and a proprietary AI-driven antibody development platform, Kyinno supports researchers and pharmaceutical companies by facilitating critical advances in biomedical research and drug development. The organization's extensive offerings include engineered cell lines for various applications, drug-resistant cell lines, and specialized kinase cell lines, among others, tailored to meet the unique needs of its clients.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2022
- Website
- www.kyinno.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Kyinno Biotechnology (康源博创)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now